Synthekine Launches with $82 Million Series A Financing to Advance Pipeline of Engineered Cytokine Therapeutics Optimized for Cancer and Autoimmune Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2HcPjcL
via IFTTT